Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma

Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma

Abstract Background Hepatitis B virus (HBV) reactivation impact negatively the prognosis of patients with HBV-related hepatocellular carcinoma (HCC). This study aimed to observe the effect of antiviral therapy (AVT) on viral reactivation and long-term outcomes after percutaneous radiofrequency ablat...

Full description

Bibliographic Details
Main Authors: Jian Liu, Hao Shen, Shengyu Huang, Jianbo Lin, Zhenlin Yan, Guojun Qian, Zhenghua Lu, Xuying Wan, Fabiao Zhang, Kui Wang, Yongjie Zhang, Jun Li
Format: Article
Language:English
Published: BMC 2023-02-01
Series:World Journal of Surgical Oncology
Subjects:
Hepatocellular carcinoma
Radiofrequency ablation
Antiviral therapy
HBV reactivation
Prognosis
Online Access:https://doi.org/10.1186/s12957-023-02921-1

Similar Items

Similar Items